TIDMIDH

RNS Number : 7685G

Immunodiagnostic Systems Hldgs PLC

25 July 2019

Results of AGM

Immunodiagnostic Systems Holdings PLC

25 July 2019

Immunodiagnostic Systems Holdings plc

Results of AGM

Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical and research markets, announces the results of its Annual General Meeting (the "Meeting") that was held at 2pm today.

Trading Update

At the meeting the Chairman, Dr Burkhard Wittek, provided a business update at the Meeting and a copy of the statement has been made available on the Company's website.

Voting Results

All resolutions put to the Meeting were decided on a show of hands and all were duly passed.

For information, details of the proxy voting are shown below:

 
              Resolution                      Votes For                 Votes                   Votes                   Votes 
                                                                        For                     Against                 Withheld 
                                                                        (as % of                (as % of 
                                                                        votes                   votes 
                                                                        cast)                   cast) 
      1. To receive the 
       accounts 
       for the year ended 31 
       March 2019 together 
       with 
       the report of the 
       Directors 
       and of the Auditor 
       thereon.                               15,236,166                100.00%                 0.00%                   0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      2. To declare a final 
       dividend for the year 
       ended 31 March 2019.                   15,236,166                100.00%                 0.00%                   0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      3. To elect as a 
       director 
       of the Company Mr Paul 
       Martin.                                14,436,059                94.75%                  5.25%                   107 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      4. To elect as a 
       director 
       of the Company Dr Peter 
       Kaspar.                                15,235,630                100.00%                 0.00%                   107 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      5. To re-appoint 
       Pricewaterhouse-Coopers 
       LLP as Auditor of the 
       Company.                               14,436,059                94.75%                  5.25%                   107 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      6. To authorize the 
       Directors 
       of the Company to 
       determine 
       the remuneration of the 
       Auditor of the Company.                15,236,166                100.00%                 100.00%                 0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      7. To approve the 
       Directors' 
       Remuneration Report for 
       the financial year 
       ended 
       31 March 2019.                         14,436,009                94.75%                  5.25%                   50 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      8. To authorise the 
       Directors 
       to allot relevant 
       securities.                            15,236,166                100.00%                 0.00%                   0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      9. To authorise the 
       disapplication 
       of pre-emption rights 
       in accordance with 
       section 
       570 of the Companies 
       Act 2006.                              14,077,487                92.40%                  7.60%                   0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
      10. To authorise the 
       Directors to make 
       market 
       purchases.                             15,236,166                100.00%                 0.00%                   0 
                                ------------------------  ----------------------  ----------------------  ---------------------- 
 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).

For further information:

   Immunodiagnostic Systems Holdings plc                              Tel : +44 (0)191 5190660 

Paul Martin, Group Finance Director

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

RAGSEFFLIFUSEDW

(END) Dow Jones Newswires

July 25, 2019 10:34 ET (14:34 GMT)

Immunodiagnostic Systems (LSE:IDH)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Immunodiagnostic Systems.
Immunodiagnostic Systems (LSE:IDH)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Immunodiagnostic Systems.